Another WGS of 638 FPC patients based on the germline DNA was conducted to analyze an explicit FPC genetic basis referring to the inherited pancreatic cancer as highly heterogeneous and reporting susceptibility genes elevating pancreatic cancer risk including, CDKN2A, BUB1B, FANCC, ATM, CPA1, BRCA2, FANCG, and PALB2 [94]. This evidence concerns the gene BRCA2 and pancreatic neoplasm.